IHS National Prescription Drug Abuse Workgroup
|
|
- Kory Marsh
- 8 years ago
- Views:
Transcription
1 IHS National Prescription Drug Abuse Workgroup A Report to the National Combined Councils June 25, 2014
2 IHS PDA Workgroup - History Director was approached in Jan 2012 at NCC by NCCMO regarding PDA epidemic Director commissioned workgroup summer of 2012 Meeting held in Rockville July 2012 workplan produced Meeting in April 2013 workplan updated Workgroup charged with carrying out workplan in fall of 2013
3 IHS PDA Workgroup - Activity Fall subgroups formed Monthly calls held with subgroup leads to monitor progress Chronic Non-Cancer Pain Management Policy and Website for Pain Management have been major outputs
4 Key Recommendations 1) Create national PDA Taskforce 2) Hire national PDA Coordinator 3) Initiate national PDA Campaign 4) Release Chronic Pain Policy 5) Deploy IHS Pain Management website 6) Develop and release PDMP Circular 7) Develop provider training 8) Implement peer review as national standard
5 Key Recommendations 1) Create national PDA Taskforce 2) Hire national PDA Coordinator 3) Initiate national PDA Campaign 4) Release Chronic Pain Policy 5) Deploy IHS Pain Management website 6) Develop and release PDMP Circular 7) Develop provider training 8) Implement peer review as national standard
6 Patient Care Subgroup Co-Chairs: CAPT Stephen Miles Rudd, MD, CMO/Deputy Director, Portland Area IHS (Portland Area) CDR Ted Hall, PharmD, Clinical Psychiatric Pharmacist/Director of Pharmacy, Ho-Chunk Nation (Bemidji Area)- Co-Lead Members Donna Linke, Psychiatric NP, Fort Thompson, SD (Aberdeen Area) Bernie Long, PT, CEO Ft. Thompson/Lower Brule, SD (Aberdeen Area) LCDR Kailee Fretland, PharmD, Clinical Pharmacist, Red Lake, MN (Bemidji Area) CDR Jennifer Betts, MD, CMO, Sonoma Co. Indian Health Project, Santa Rosa, CA (California Area) Jennie Wei, MD, Gallup Indian Medical Center, Gallup, NM (Navajo Area)
7 Patient Care Subgroup Extensively assisted with IHS Pain Management web site development and launch. researched and defined evidence based, safe non-malignant chronic pain management best practices (incorporated into website) Contributed to final revisions of the IHS Chronic Non-Cancer Pain Management Policy (recently approved). National P&T Committee Pain Management Review May 2014 meeting focused on review of 7 drug classes related to pharmacotherapy for pain management Conducted a survey of Chief Pharmacists related to opioid issues (n=104) Produced Formulary Briefs on each drug class (published on NPTC website: ) Tele-partnerships- Engaged in cross collaboration with the PDA Education subgroup resulting in the IHS Tele-Behavioral Health Center of Excellence Pain and Addiction Consultation ECHO.
8 Policy Subgroup Chronic Non-Cancer Pain Policy Release Reinforce Agency stance on medical marijuana Standardized policy on proxy pick-up Standardized policy on employee drug testing
9 Education Subgroup Essential Training for Providers Educational Portals Discussion Boards/Forums Community education resources/materials
10 Monitoring Subgroup Prescription Drug Monitoring Program Circular Status: authored pending approval EHR standardization Status: best practice document authored to be included in next website iteration Patient Urine Drug Testing Best Practice Guideline Status: completed and hosted on pain management website PDMP Peer Review Status: draft document pending leadership comment Naloxone (Clinical) Status: First Responder: in use in Cherokee, pending in Red Lake and White River. Community poster, protocol, and competencies developed for intranasal product. Co-prescribing: in development Pending items: PDMP outcomes measures Patient photo capture in VistaImaging to assist in patient identification (issues with HIM uptake).
11 Disposal/Storage Subgroup IHS Pain Management website: Safe Storage of Medications at Homes Lock It Up: Medicine Safety In Your Home, a video from the Food and Drug Administration Safeguard My Meds Talk About Prescriptions Patient Disposal of Medications Drug Take-Back Programs Resources for disposal in trash FDA website - list of drugs recommended for flushing
12 Enforcement Subgroup Goals of the Enforcement Best Practice To inform I/T/U Staff regarding the relevant regulatory and operational issues surrounding the security, storage, furnishing, dispensing, documentation, and critical incident management related to the use of Controlled Substances. To inform I/T/U Staff regarding Tribal Wellness/Drug Courts as a model for assisting patients to bypass initial or repeat criminal proceedings related to Substance Abuse offenses and to connect them with resources to assist them to build skills and make positive life changes to help prevent relapse related to Substance Abuse. To serve as a resource for I/T/U sites to create, revise, or optimize an Enforcement program related to the use of Controlled Substances at their facilities and to engage I/T/U facility leadership on Enforcement issues.
13 Enforcement Subgroup Content Areas Physical Security of Medications Risk Management/Critical Incident Response Prescription Pad/Paper Security Documentation of Controlled Substance Use Engaging I/T/U Leadership Developing Linkages/Supporting Tribal Drug Courts
14 Interagency Collaboration Subgroup Purpose: To strengthen the federal agency response to prescription drug misuse and abuse for American Indians and Alaska Natives Coordinates with the Office on National Drug Control Policy Implementation of the National Drug Control Strategy Chapter 3 and monitors 8 process measures Established a new AI/AN Interagency PDA Group Leveraging federal PDA resources Interagency Tribal Consultation Plan on PDA Explore opportunities to implement medication assisted treatment (MAT)/office-based opioid therapy (OBOT)
15 Thank You IHS National Prescription Drug Abuse Workgroup CAPT Harry J Brown, MD harry.brown@ihs.gov
Prescription Drug Abuse in Tribal. Plan.
Prescription Drug Abuse in Tribal Communities: A Public Health Action Plan. Anne Helene Skinstad, Ph.D. Director, National American Indian and Alaska Native Addiction Technology Transfer Center Associate
More informationThe Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section
The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who
More informationColorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy
Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace
More informationOffice of Information Technology - Albuquerque
Office of Information Technology - Albuquerque Ryan Garcia (Contractor) Business System Analyst Indian Health Service, Office of Information Technology Ryan Garcia is a Business Systems Analyst and contractor
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES STATEMENT. ROBERT McSWAIN DEPUTY DIRECTOR INDIAN HEALTH SERVICE BEFORE THE SENATE COMMITTEE ON INDIAN AFFAIRS
DEPARTMENT OF HEALTH AND HUMAN SERVICES STATEMENT OF ROBERT McSWAIN DEPUTY DIRECTOR INDIAN HEALTH SERVICE BEFORE THE SENATE COMMITTEE ON INDIAN AFFAIRS OVERSIGHT HEARING ON THE PROBLEM OF METHAMPHETAMINE
More informationRx and Heroin Abuse :Taking Action
Rx and Heroin Abuse :Taking Action Dan Hicks, Manager, Prevention Services November 21, 2014 Page 1 Rx Abuse & Heroin: Increasing Awareness Young people are abusing prescription drugs at alarming rates.
More informationPart 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015
Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol New Mexico Pharmacists Association & Project ECHO 2014 This training fulfills the educational requirement for pharmacists in
More informationGovernor s Task Force on Mental Health and Substance Use. www.ncdhhs.gov/mhsu
Governor s Task Force on Mental Health and Substance Use www.ncdhhs.gov/mhsu Problem Statement 97 Painkiller prescriptions per 100 North Carolinians Number of deaths by drug overdose in North Carolina
More informationARIZONA SUBSTANCE ABUSE PARTNERSHIP Governor s Office for Children, Youth and Families
Rx DRUG MISUSE AND ABUSE INITIATIVE IMPLEMENTATION PLAN ARIZONA SUBSTANCE ABUSE PARTNERSHIP Governor s Office for Children, Youth and Families Introduction The Arizona Rx Drug Misuse and Abuse Initiative
More informationColorado Plan to Reduce Prescription Drug Abuse
Colorado Plan to Reduce Prescription Drug Abuse September 2013 Kelly Perez Policy Advisor Office of Governor John Hickenlooper The Colorado Team (2012/2013) Christine Adams Statistical Analyst/Researcher
More informationSTATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council
STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that
More informationThe Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community
The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community November 2014 INTRODUCTION The Heroin
More informationOpioid Agreement for Center for Pain Management S.C.
Opioid Agreement for Center for Pain Management S.C. Patient Name: DOB: I am the patient named above. I have agreed to use pain medication as part of my treatment for chronic pain. I understand that these
More informationThe Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE
The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion Angela Huskey, PharmD, CPE Case Bill is a 47 year old man with a history of low back pain and spinal stenosis Not a real
More informationPrescription Opioid Overdose & Misuse in Oregon
Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon In-State Policy Workshop NGA Policy Academy: Reducing
More informationMayor s Task Force On Prescription Painkiller Abuse
Mayor s Task Force On Prescription Painkiller Abuse Interim Report January 2013 BACKGROUND In response to a growing epidemic, in late 2011 Mayor Bloomberg created the multi-agency Task Force on Prescription
More informationColorado Consortium for Prescription Drug Abuse Prevention:
Colorado Consortium for Prescription Drug Abuse Prevention: Quarterly Update to the SATF Robert Valuck, PhD, RPh Coordinating Center Director Helen Kaupang Associate Director Friday, February 7, 2014 #2
More informationOREGON DRUG CONTROL UPDATE. Drug Use Trends in Oregon
OREGON DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Oregon. Oregon At-a-Glance: In 2009-2010, Oregon was one of the top ten states
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES STATEMENT ROBERT G. MCSWAIN ACTING DIRECTOR INDIAN HEALTH SERVICE BEFORE THE
DEPARTMENT OF HEALTH AND HUMAN SERVICES STATEMENT OF ROBERT G. MCSWAIN ACTING DIRECTOR INDIAN HEALTH SERVICE BEFORE THE SENATE COMMITTEE ON INDIAN AFFAIRS ON ADDRESSING HARMFUL EFFECTS OF DANGEROUS DRUGS
More informationDISPOSAL OF CONTROLLED SUBSTANCES
DISPOSAL OF CONTROLLED SUBSTANCES WELCOME Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association Outline of Today s 2/2/2 PRESENTER Jan Harris Director, EHS Customer Compliance
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES STATEMENT OF YVETTE ROUBIDEAUX M.D., M.P.H., DIRECTOR INDIAN HEALTH SERVICE BEFORE THE
DEPARTMENT OF HEALTH AND HUMAN SERVICES STATEMENT OF YVETTE ROUBIDEAUX M.D., M.P.H., DIRECTOR INDIAN HEALTH SERVICE BEFORE THE SENATE COMMITTEE ON INDIAN AFFAIRS May 24, 2012 STATEMENT OF THE INDIAN HEALTH
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationDEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services. NEW products from the Medicare Learning Network (MLN)
Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management. The Centers
More informationKing County Drug Trends 2015
Brad Finegood, MA, LMHC Assistant Division Director, Acting RSN Administrator Prevention and Treatment Coordinator King County Behavioral Health and Recovery Division Caleb Banta-Green PhD, MPH, MSW Senior
More informationHow To Help People Who Are Addicted To Prescription Drugs And Heroin
Community Behavioral Healthcare Association of Illinois Frank Anselmo, MPA Chief Executive Officer 3085 Stevenson Drive, Suite 203 Springfield, Illinois 62703 Phone: 217/585-1600 Fax: 217/585-1601 www.cbha.net
More informationCommunity Response to Heroin and Opiate Usage in Northern Rice County
Community Response to Heroin and Opiate Usage in Northern Rice County Minnesota Rural Health Conference June 28 th and 29 th 2010 Presented By Kathleen Meier Andrew Yurek Northfield Hospital and Clinics
More informationPRESCRIPTION DRUG. Mayor Teresa Jacobs Prescription Drug Task Force. Healthcare & Pharmacy Subcommittee Recommendations.
PRESCRIPTION DRUG Mayor Teresa Jacobs Prescription Drug Task Force Healthcare & Pharmacy Recommendations Orange County Underaged Drinking Task Force Report Co-Chairs: Marlin Hutchens, Vice President of
More informationThe Prescription Drug Abuse and Heroin Crisis: New York s Response
The Prescription Drug Abuse and Heroin Crisis: New York s Response Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 The Connection States with more opioid
More informationTestimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition
Testimony on Opioid Overdose Prevention Daniel Raymond, Policy Director, Harm Reduction Coalition Presented on March 25, 2014 to the House Appropriations Subcommittee on Labor, Health and Human Services,
More informationTitle: The Certified Medication Assisted Treatment Advocate (CMA) Training Course
The American Association for the Treatment of Opioid Dependence, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org,
More informationPRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES
PRESCRIPTION DRUG ABUSE, ADDICTION AND DIVERSION: OVERVIEW OF STATE LEGISLATIVE AND POLICY INITIATIVES A THREE PART SERIES PART 3: PRESCRIBING OF CONTROLLED SUBSTANCES FOR NON-CANCER PAIN PREPARED BY THE
More informationGuidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998
Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles
More informationEXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org
EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org Disclosures Project Lazarus Zogenix Charitable Contribution 2015 Kaléo Charitable Contribution
More informationSubstance Use: Addressing Addiction and Emerging Issues
MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population
More informationData-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014
Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014 Denise Paone and Alexandra Harocopos Bureau of Alcohol & Drug Use Prevention, Care & Treatment New York City Department
More informationState Substance Abuse Agencies and Prescription Drug Abuse Initial Results from a NASADAD Membership Inquiry
State Substance Abuse Agencies and Prescription Drug Abuse Initial Results from a NASADAD Membership Inquiry Cliff Bersamira, Research Analyst Rick Harwood, Research and Program Applications Director National
More informationArizona. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Arizona State Board of Pharmacy Pharmacy Board Wright, Dean - Program Director P O Box 18520 Phoenix AZ 85005 Office: (602) 771-2744
More informationMichigan Guidelines for the Use of Controlled Substances for the Treatment of Pain
Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Section I: Preamble The Michigan Boards of Medicine and Osteopathic Medicine & Surgery recognize that principles of quality
More informationAchieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015
Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities
More informationSubstance Abuse Treatment Admissions Data
1 ARIZONA DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Arizona. Arizona At-a-Glance: In 2010-2011, Arizona was one of the top ten
More informationNational Perspectives in Medication Assisted Treatment
National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit
More information18% Role of Pharmacist-Provided Medication Reviews in Workers Compensation Claims Management. Introduction. Role of the Pharmacist
Role of Pharmacist-Provided Medication Reviews in Workers Compensation Claims Management Benjamin Link, PharmD, RPh Introduction According to information from the National Council on Compensation Insurance
More informationPrescriber Behavior, Pain Treatment and Addiction Treatment
Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy
More informationWashington State Interagency Opioid Working Plan
Washington State Interagency Opioid Working Plan INTRODUCTION January 2016 Washington State is currently experiencing an opioid abuse and overdose crisis involving prescription opioids and heroin. Approximately
More informationCURES Prescription Drug Monitoring Program
California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug
More informationMinimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society
More informationPharmacy Category Day Tuesday, May 19, 2015
Pharmacy Category Day Tuesday, May 19, 2015 8:00 am - 8:30 am Health Equity Considerations in Pharmacy Practice Speaker: CDR Lori Hall, PharmD, USPHS, Program Consultant, Centers for Disease Control and
More informationUNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths
UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths Joanna G Katzman, M.D., M.S.P.H Director, UNM Pain Center Associate Professor,
More informationMassachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
More informationNew Mexico. Contact Information. Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - PMP Director 5500 San Antonio Drive NE Albuquerque NM 87109 Office: (505) 222-9837 Fax: (505) 222-9845 Email: @state.nm.us
More informationSubstance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008
Treatment Episode Data Set The TEDS Report July 15, 010 Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 008 In Brief The proportion of all substance abuse treatment admissions
More informationPreventing Prescription Drug Abuse: An Important Role for State Injury Prevention Programs
Preventing Prescription Drug Abuse: An Important Role for State Injury Prevention Programs 2012 Joint tannual lmeeting of the Sf Safe States t Alliance and CDC Core Violence and Injury Prevention Program
More informationPrescription Drug Abuse and Overdose: Public Health Perspective
Prescription Drug Abuse and Overdose: Public Health Perspective [Residency educators may use the following slides for their own teaching purposes.] CDC s Primary Care and Public Health Initiative October
More informationLocal Health Improvement Plan (LHIP) Update and Community Health Needs Assessment (CHNA) Plans
Local Health Improvement Plan (LHIP) Update and Community Health Needs Assessment (CHNA) Plans Presentation to the Community Health Advisory Committee July 16, 2015 Daniel Coulter, MPH: daniel.coulter@maryland.gov
More informationWashington. Contact Information. Email: Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Baumgartner, Chris - Director P O Box 47852 Olympia WA 98504-7852 Office: (360) 236-4806 Fax: (360) 236-2901 Email: Washington Washington
More informationARIZONA DRUG CONTROL UPDATE. Drug Use Trends in Arizona
ARIZONA DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Arizona. Arizona At-a-Glance: In 2009-2010, Arizona was one of the top ten
More informationQUEEN ANNE S COUNTY STRATEGIC PLAN ALCOHOL AND DRUG ABUSE SERVICES
QUEEN ANNE S COUNTY STRATEGIC PLAN ALCOHOL AND DRUG ABUSE SERVICES 2016 2018 INTRODUCTION Local councils are established under Chapters 237 and 238 of the Acts of the General Assembly of Maryland of 2004,
More informationA New Generation of Prescription Monitoring Programs: Best & Promising Practices
A New Generation of Prescription Monitoring Programs: Best & Promising Practices National PDMP Meeting Washington, DC September 25, 2013 Presented by John L Eadie Why Is a New Generation of PDMPs Being
More informationFor a Healthier America: Reducing Prescription Drug Misuse and Abuse
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
More informationTESTIMONY. March 17, 2014. Rutland, VT
Community Solutions to Breaking the Cycle of Heroin & Opioid Addiction TESTIMONY Harry Chen, MD, Commissioner of Health March 17, 2014 Senate Committee on the Judiciary Franklin Conference Center at the
More informationA Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death
A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death 2013 WPHA-WALHDAB Annual Conference Wednesday, May 22: 2:00-2:35 pm Lisa Bullard-Cawthorne, MS, MPH OPIATE PREVALENCE IN DANE
More informationRecommendations of the Governor s Task Force on Prescription Drug and Heroin Abuse
Recommendations of the Governor s Task Force on Prescription Drug and Heroin Abuse Jodi Manz, MSW Policy Advisor Office of the Secretary of Health and Human Resources October 7, 2015 Rates of of Opioid
More informationIncreasing Access to Opioid Addiction Treatment
Report to The Vermont Legislature Increasing Access to Opioid Addiction Treatment In Accordance with Act 75, 2013, Section 14b An Act Relating to Strengthening Vermont s Response to Opioid Addiction and
More informationColorado. Contact Information. Statistics. Technological Capabilities
PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Colorado State Board of Pharmacy Pharmacy Board http://www.hidinc.com/copdmp pdmpinqr@state.co.us Rivera, Janina - PDMP Administrator
More informationProtecting your employees, physicians and you.
Protecting your employees, physicians and you. Opioid abuse is being talked about every day. Modern Medical has a solution - now with real outcomes. Opioids are the most common drugs prescribed in workers
More informationDisclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu. The West Virginia Model
West Virginia University School of Medicine BEHAVIORAL MEDICINE & PSYCHIATRY Morgantown, WV Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu Disclosure Reckitt Benckiser
More informationAnnual Harold Rogers Prescription Drug Monitoring Program onitoring. Commissioner Cheryl Bartlett, RN Massachusetts Department of Public Health
Annual Harold Rogers Prescription Drug Monitoring Program onitoring Commissioner Cheryl Bartlett, RN Massachusetts Department of Public Health Current Substance Use: Massachusetts vs. Northeast Region
More informationPrescription Drug Abuse
DELAWARE DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Delaware. Delaware At-a-Glance: In 2007-2008, Delaware was one of the top
More informationCMS Medicine Dish Shows
CMS Medicine Dish Shows October 19, 2011: "Medicare Part D and Program Updates IHS and CMS experts discussed Medicare Part D and recent Medicare program changes: New dates for Open Enrollment Creditable
More informationRULES OF DEPARTMENT OF HEALTH DIVISION OF PAIN MANAGEMENT CLINICS CHAPTER 1200-34-01 PAIN MANAGEMENT CLINICS TABLE OF CONTENTS
RULES OF DEPARTMENT OF HEALTH DIVISION OF PAIN MANAGEMENT CLINICS CHAPTER 1200-34-01 PAIN MANAGEMENT CLINICS TABLE OF CONTENTS 1200-34-01-.01 Purpose 1200-34-01-.06 Notifications 1200-34-01-.02 Definitions
More informationUpdated on Substance Abuse Treatment Centers in New Mexico
Updated on Substance Abuse Treatment Centers in New Mexico Update on Substance Abuse Treatment Centers in New Mexico Presentation to: The Legislative Health and Human Services Committee Wayne W. Lindstrom,
More informationSPPAN Policy and Advocacy Priorities 2015
SPPAN S 2015 POLICY AND ADVOCACY PRIORITIES SPPAN surveyed its stakeholders to help identify the top policy priorities for 2015. Below, you will find our top policy issues for 2015 followed by information
More informationTraining of Addiction Treatment Providers in Massachusetts. Sarah Ruiz, MSW Bureau of Substance Abuse Services MA Department of Public Health
Training of Addiction Treatment Providers in Massachusetts Sarah Ruiz, MSW Bureau of Substance Abuse Services MA Department of Public Health July 1, 2015 Naloxone and Overdose Prevention: MA Timeline 2005:
More informationOREGON DRUG CONTROL UPDATE. Drug Use Trends in Oregon. Substance Abuse Treatment Admissions Data
OREGON DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Oregon. Oregon At-a-Glance: In 2007-2008, Oregon ranked first among all states
More informationReport to the Legislature: Interstate Prescription Data Exchange MN Prescription Monitoring Program
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Minnesota Board of
More informationThe Public Health and Safety Challenges of Treating Chronic Pain: The Medical Perspective. A Proposed CMS Platform
Recommendations of the Committee on Workers Compensation and Personal Injury and The Special Advisers on Prescription Drug Abuse Approved by the CMS House of Delegates September 21, 2013 The Public Health
More informationWhat Every Practitioner Needs to Know About Controlled Substance Prescribing
What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of
More informationFDA Advisory Committee Hearing on Potential Rescheduling of Hydrocodone: Pharmacist and Pharmacy Issues to Consider
FDA Advisory Committee Hearing on Potential Rescheduling of Hydrocodone: Pharmacist and Pharmacy Issues to Consider January 24, 2013 FDA White Oak Campus Steve Simenson, BPharm, FAPhA, DPNAP APhA President
More informationThePrescriptionDrug AbuseEpidemicinWisconsin. WisconsinNursesAsociation TaskForceonPrescriptionDrugAbuse October2013
ThePrescriptionDrug AbuseEpidemicinWisconsin WisconsinNursesAsociation TaskForceonPrescriptionDrugAbuse October2013 WisconsinNursesAsociation 6117MononaDrive Monona,WI53716 608.221.0383 www.wisconsinnurses.org
More informationDepartment of Veterans Affairs (VA) and. Indian Health Service (IHS) Memorandum of Understanding (MOU) Annual Report.
Department of Veterans Affairs (VA) and Indian Health Service (IHS) Memorandum of Understanding (MOU) Annual Report Fiscal Year 2014 Prepared by the VA - Center for Applied Systems Engineering On Behalf
More information2014 Tribal Consultation U.S. Department of Health and Human Services Regions VII and VIII. Prescription Drug Abuse in Indian Country.
2014 Tribal Consultation U.S. Department of Health and Human Services Regions VII and VIII Prescription Drug Abuse in Indian Country April 8, 2014 Prescription Drug Abuse: The Problem Kimberly Patton,
More information3/27/2012. Supply and Demand: The Substance Abuse/Misuse Market Triangle
Substance Abuse and Misuse: A Tragic Market That Can Be Curtailed Tennessee Department of Health Protect, promote, and improve the health and prosperity of persons in the State of Tennessee. John J. Dreyzehner,
More informationCOLORADO DRUG CONTROL UPDATE. Drug Use Trends in Colorado
COLORADO DRUG CONTROL UPDATE This report reflects significant trends, data, and major issues relating to drugs in the State of Colorado. Colorado At-a-Glance: The rate of drug-induced deaths in Colorado
More information2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
More informationPresentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
More informationEvaluating Options for the Integration of Electronic Medical Records With the Vermont Prescription Monitoring System
Report to The Vermont Legislature Evaluating Options for the Integration of Electronic Medical Records With the In Accordance with Act 75, (2013), Section 13a, An Act Relating to Strengthening Vermont
More informationBuilding Organizational Infrastructure to Treat Chronic Pain and Prevent Abuse of Prescription Medications. June 5, 2014
Building Organizational Infrastructure to Treat Chronic Pain and Prevent Abuse of Prescription Medications June 5, 2014 Aaron Williams, MA (webinar moderator) Director Training and Technical Assistance
More informationMark Siemon, RN, APHN-BC, MPH, MSN, CPH, PhDc 1
Mark Siemon, RN, APHN-BC, MPH, MSN, CPH, PhDc 1 EDUCATION MARK SIEMON, RN, APHN-BC, MPH, MSN, CPH 1400 VASSAR DR NE APT C ALBUQUERQUE, NM 87106-2607 (505) 306-0424 (msiemonunm@gmail.com) 2010 Doctorate
More informationLicensure of Substance Abuse Treatment Programs Required Amendments
Licensure of Substance Abuse Treatment Programs Required Amendments Public Health Council August 12, 2015 Jim Cremer, Deputy Director Erica Piedade, Director of Quality Assurance & Licensing, Overview
More informationCENTER FOR RURAL PA PUBLIC HEARING OPIATE ABUSE TREATMENT AND RECOVERY SERVICES. York, PA. August 18, 2015
CENTER FOR RURAL PA PUBLIC HEARING OPIATE ABUSE TREATMENT AND RECOVERY SERVICES York, PA August 18, 2015 Hello. My name is Jack Carroll, and I m the Executive Director of the Cumberland-Perry Drug and
More informationAmerican Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement on Office-based Opioid Agonist Treatment (OBOT) BACKGROUND Methadone maintenance treatment of opioid addiction was developed in 1965 and implemented
More informationRE: Medication Assisted Treatment for Opioid Use Disorders RIN 0930-AA22
May 31, 2016 Substance Abuse and Mental Health Services Administration Department of Health and Human Services ATTN: Jinhee Lee, SAMHSA 5600 Fishers Lane Room 13E21C Rockville, MD 20857 RE: Medication
More informationMONTGOMERY COUNTY OPIATE TASK FORCE MEETING February 28, 2012 2:00 PM 4:00 PM
MONTGOMERY COUNTY OPIATE TASK FORCE MEETING February 28, 2012 2:00 PM 4:00 PM Present: Robert Carlson, WSU/CITAR Jim Gross, Public Health-Dayton & Mont. Co. Chief Deputy Scott Landis, Sheriff s Office
More informationCo-Chairs Delegate John O Bannon, M.D. Jennifer Lee, M.D., Deputy Secretary, Health and Human Resources
Executive Order Number 29 DRAFT Minutes of the Treatment Workgroup Patrick Henry Building Richmond, Virginia Co-Chairs Delegate John O Bannon, M.D. Jennifer Lee, M.D., Deputy Secretary, Health and Human
More informationConnecting Prescribers and Dispensers to PDMPs through Health IT: Six Pilot Studies and Their Impact
Page 1 Introduction Prescription drug misuse and overdose is one of the fastest growing health epidemics in the United States. To address the prescription drug abuse problem, many states have established
More informationOpioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians
Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse
More informationPolicy for Prescribing and Dispensing Opioids
Policy for Prescribing and Dispensing Opioids Colorado Dental Board, Colorado Medical Board, State Board of Nursing, and State Board of Pharmacy In collaboration with the Nurse-Physician Advisory Task
More informationVermont Prescription Drug Abuse Workgroup Final Report Workgroup Recommendations
Vermont Prescription Drug Abuse Workgroup Final Report Workgroup Recommendations Vermont Prescription Drug Abuse Workgroup healthvermont.gov dps.vermont.gov Executive Summary In 2008 the Prescription Drug
More informationSubstance Abuse Treatment Admissions for Abuse of Benzodiazepines
Treatment Episode Data Set The TEDS Report June 2, 2011 Substance Abuse Treatment Admissions for Abuse of Benzodiazepines Benzodiazepines are a class of central nervous system depressant drugs that are
More informationPortland Area Indian Health Service & the Northwest Portland Area Indian Health Board
Portland Area Indian Health Service & the Northwest Portland Area Indian Health Board Northwest Tribal Substance Abuse Action Plan A Five-Year Strategic Plan for the Tribes of Idaho, Oregon, and Washington
More information